---
title: ExperTrials vs The Micron Group
slug_a: expertrials
slug_b: micron-group
site: cro
review_signal_gate: closed
canonical_path: /compare/expertrials/micron-group
---

# ExperTrials vs The Micron Group

Side-by-side profile data from each company listing on this directory.

## ExperTrials

- Profile: [/companies/expertrials](/companies/expertrials)

ExperTrials — European-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA.

Services: 12. Modalities: 0. Indications: 6. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- EU EMA Regulatory Strategy
- Device & Combination Product Services

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Cardiovascular
- Infectious Disease
- Rare Disease
- Gastroenterology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## The Micron Group

- Profile: [/companies/micron-group](/companies/micron-group)

The Micron Group — Global CRO delivering clinical trial management, regulatory consultancy, data management, and medical writing for biotech, pharma, and medical device companies across Phase I–IV studies and real-world evidence programs.

Services: 11. Modalities: 0. Indications: 1. Locations: 5. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Device & Combination Product Services

### Modalities

- Data not yet provided.

### Indications

- Infectious Disease

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)